T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 2.195 NOK -3.52% Market Closed
Market Cap: 690.1m NOK

Intrinsic Value

TRMED's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one TRMED stock under the Base Case scenario is 0.093 NOK. Compared to the current market price of 2.195 NOK, Thor Medical ASA is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TRMED Intrinsic Value
0.093 NOK
Overvaluation 96%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Thor Medical ASA

TRMED
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TRMED cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Thor Medical ASA
OSE:TRMED
NO
Biotechnology
Market Cap
690.1m NOK
IPO
Jul 7, 2014
NO
Biotechnology
Market Cap
690.1m NOK
IPO
Jul 7, 2014
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TRMED?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Thor Medical ASA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Thor Medical ASA

Current Assets 33.7m
Cash & Short-Term Investments 29.6m
Receivables 4.1m
Non-Current Assets 286.4m
PP&E 1.9m
Intangibles 284.5m
Efficiency

Free Cash Flow Analysis
Thor Medical ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Thor Medical ASA

Revenue
0 NOK
Operating Expenses
-20.3m NOK
Operating Income
-20.3m NOK
Other Expenses
-19.3m NOK
Net Income
-39.6m NOK
Fundamental Scores

TRMED Profitability Score
Profitability Due Diligence

Thor Medical ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

42/100
Profitability
Score

Thor Medical ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

TRMED Solvency Score
Solvency Due Diligence

Thor Medical ASA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
82/100
Solvency
Score

Thor Medical ASA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRMED Price Targets Summary
Thor Medical ASA

There are no price targets for TRMED.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Thor Medical ASA
does not pay dividends
Shareholder Yield

Current shareholder yield for TRMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one TRMED stock?

The intrinsic value of one TRMED stock under the Base Case scenario is 0.093 NOK.

Is TRMED stock undervalued or overvalued?

Compared to the current market price of 2.195 NOK, Thor Medical ASA is Overvalued by 96%.

Back to Top